Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs... see more

TSX:TH - Post Discussion

Theratechnologies Inc > MD Anderson trial post?
View:
Post by Wino115 on Mar 31, 2021 10:47am

MD Anderson trial post?

I believe JFM or Qwerty were able to find the trial up on the MD Anderson trial website and posted the link. I couldn't find that old Stockhouse post.   The lead investigator is Funda Meric-Bernstam; however, I was not able to find it anywhere on the MD Anderson site? Do you think THTX moved it over to someone else or a different facility? Perhaps something happened there.  The clinicaltrials website still lists her as lead investigator but it hasn't been updated since January. Bit of a mystery.
Comment by MHemorrhage on Mar 31, 2021 1:21pm
I assume all is still same, recall THTX March 24 news release: Funda Meric-Bernstam, M.D., Chair of the Department of Investigational Cancer Therapeutics at The University of Texas MD Anderson Cancer Center is the Lead Principal Investigator of the Phase 1 trial for TH1902.
Comment by Wino115 on Mar 31, 2021 1:34pm
Yes, but if you search MD Anderson, it's nowhere to be found as of today. I believe someone posted it before, so it's disappeared from their clinical trials database you can search.
Comment by qwerty22 on Mar 31, 2021 4:01pm
There are public statements on the Gettysburg, Penn site about the trial dating back to March 10th, nothing has ever appeared at either MD Anderson or Cedar Sinai, which is another th1902 site I believe. Here is the cedar Sinai site. https://cancertrialinfo.csmc.edu/index.php#tab4
Comment by qwerty22 on Mar 31, 2021 3:54pm
I've been occasionally (regularly) looking at the MD Anderson trials website search. The th1902 trial hasn't appeared there yet, From my perspective it hasn't appeared then disappeared, it just hasn't yet gone to that searchable database. I could speculate a couple of reasons but basically I'm not too concerned atm. I think this is why the company hedged their bets on a Q2 ...more  
Comment by SPCEO1 on Mar 31, 2021 3:56pm
In my experience, updating the Clinicaltrials.gov website seems to be about the lowest priority a company has. I am not sure whay that is but they never seem to be updated in anything remotely resembling a timely fashion.
Comment by scarlet1967 on Mar 31, 2021 3:57pm
I am not concerned either but I send an inquiry to MD Anderson today if I get any response I let you know.
Comment by qwerty22 on Mar 31, 2021 4:11pm
You can do as you choose but I wouldn't endorse this sort of behaviour.  shareholders pestering companies partners it's not really productive, I just don't think the partner is very going to appreciate it or think it's their role to deal with another companies shareholders.
Comment by scarlet1967 on Mar 31, 2021 4:23pm
It's a public information which should be disclosed to anyone with any interest. I didn't ask the question as TH's shareholder. There are folks out there following these trials for other reasons than financials for instance I have a niece with MS and I have been communicating with many organizations in charge of experimental research studies I wouldn't class that as harassment.
Comment by qwerty22 on Mar 31, 2021 4:32pm
No, I'm not criticizing you. I followed a telemedicine company that reported each of it's new contracts with clinical partners. Some of the crazier shareholders decided it was a good idea to email the medical facilities to 'enquire' about the new service and it ended up with these businesses having to deal with a multitude of requests when there had previously been none. It ...more  
Comment by scarlet1967 on Mar 31, 2021 4:38pm
I understand your concern, for whoever who reads these posts the initiation of the trial is public information but anything after that it's not!
Comment by scarlet1967 on Mar 31, 2021 5:34pm
To be clear I only submitted an online question to the Center I also believe as mentioned by others sending direct email causes distraction also no point for duplicate submissions if they get back to me I will report it. We have received your question. We will contact you by the end of the next business day with our answer or to collect any additional details we need to provide you with the most ...more